Unlocking the Potential of Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists for Weight Loss and Heart Health

from TheBrief.Health · host TheBrief.Health

Emerging obesity treatments may deliver both weight-loss and cardiovascular benefits, offering new options to reduce heart disease risk while addressing the growing obesity epidemic.

Episode metadata supplied by the publisher feed · Published Jun 12, 2026

Embed this episode

Attribution link and audio player

Ready to play

Unlocking the Potential of Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists for Weight Loss and Heart Health

0:00 1:32

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of TheBrief.Health?

This episode is 1 minute long.

When was this TheBrief.Health episode published?

This episode was published on June 12, 2026.

Can I download this TheBrief.Health episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!